Medicines Patent Pool Takes Novel Approach With Roche In Valcyte Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche and the Medicines Patent Pool have signed a five-year deal that will allow developing countries to achieve faster access to the Swiss company’s CMV drug, Valcyte.